Rock-Springs-Capital-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
96
Total Value
1747790415
Accession Number
0001172661-25-001953
Form Type
13F-HR
Manager Name
Rock-Springs-Capital-Management-Lp
Data Enrichment
94% identified
90 identified6 unidentified

Holdings

96 positions
Manager:
Search and click to pin securities to the top
Janux Therapeutics, Inc.
Shares:204.5K
Value:$5.5M
Dyne Therapeutics, Inc.
Shares:524.5K
Value:$5.5M
38341PAA0
Shares:
Value:$5.3M
Mineralys Therapeutics, Inc.
Shares:320.8K
Value:$5.1M
Cullinan Therapeutics, Inc.
Shares:644.6K
Value:$4.9M
64157F103
Shares:800.5K
Value:$4.7M
Bicara Therapeutics Inc.
Shares:336.1K
Value:$4.4M
NOVAVAX INC
Shares:650.0K
Value:$4.2M
G52441105
Shares:145.0K
Value:$3.6M
Gossamer Bio, Inc.
Shares:3.3M
Value:$3.6M
Pulmonx Corp
Shares:503.7K
Value:$3.4M
Inozyme Pharma, Inc.
Shares:3.4M
Value:$3.1M
Beam Therapeutics Inc.
Shares:150.0K
Value:$2.9M
Alphatec Holdings, Inc.
Shares:267.5K
Value:$2.7M
Sagimet Biosciences Inc.
Shares:787.8K
Value:$2.6M
EDAP TMS SA
Shares:1.3M
Value:$2.5M
Jasper Therapeutics, Inc.
Shares:545.2K
Value:$2.3M
LENZ Therapeutics, Inc.
Shares:83.1K
Value:$2.1M
REGENERON PHARMACEUTICALS, INC.
Shares:2.8K
Value:$1.8M
Apellis Pharmaceuticals, Inc.
Shares:80.0K
Value:$1.7M